Education
About Us
Working with TipRanks
Follow Us
Jaguar Animal Health (JAGX)
NASDAQ:JAGX
RESEARCH TOOLSreports
JAGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.75 - $110.75
Previous CloseN/A
Volume188.05K
Average Volume (3M)115.43K
Market Cap
$5.13M
Enterprise Value$36.61M
Total Cash (Recent Filing)$5.69M
Total Debt (Recent Filing)$38.34M
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Aug 13, 2025EPS Estimate
-7.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-16.70
Shares Outstanding1,264,658
10 Day Avg. Volume68,273
30 Day Avg. Volume115,431
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)4.44
Price to Sales (P/S)0.00
P/FCF Ratio-0.13
Enterprise Value/Market Cap7.13
Enterprise Value/Revenue0.83
Enterprise Value/Gross Profit3.87
Enterprise Value/Ebitda-0.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jaguar Animal Health News
PremiumCompany Announcements
Jaguar Health Announces $1.5M Direct Stock Offering
PremiumCompany Announcements
Jaguar Animal Health: Mixed Sentiments in Latest Earnings Call
PremiumCompany Announcements
Jaguar Health Reports Q1 2025 Financial ResultsPremiumCompany Announcements
Jaguar Animal Health Executes Stock Exchange Agreements
PremiumCompany Announcements
Jaguar Health Highlights Promising Crofelemer Study ResultsOptions Prices
Currently, No data available
---
Ownership Overview
32.95% Insiders
8.30% Mutual Funds
0.08% Other Institutional Investors
58.51% Public Companies and Individual Investors
JAGX FAQ
What was Jaguar Animal Health’s price range in the past 12 months?
Jaguar Animal Health lowest stock price was $3.75 and its highest was $110.75 in the past 12 months.
What is Jaguar Animal Health’s market cap?
Jaguar Animal Health’s market cap is $5.13M.
When is Jaguar Animal Health’s upcoming earnings report date?
Jaguar Animal Health’s upcoming earnings report date is Aug 13, 2025 which is in 65 days.
How were Jaguar Animal Health’s earnings last quarter?
Jaguar Animal Health released its earnings results on May 15, 2025. The company reported -$16.7 earnings per share for the quarter, missing the consensus estimate of N/A by -$16.7.
Is Jaguar Animal Health overvalued?
According to Wall Street analysts Jaguar Animal Health’s price is currently Overvalued.
Does Jaguar Animal Health pay dividends?
Jaguar Animal Health does not currently pay dividends.
What is Jaguar Animal Health’s EPS estimate?
Jaguar Animal Health’s EPS estimate is -7.13.
How many shares outstanding does Jaguar Animal Health have?
Jaguar Animal Health has 1,264,658 shares outstanding.
What happened to Jaguar Animal Health’s price movement after its last earnings report?
Jaguar Animal Health reported an EPS of -$16.7 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.859%.
Which hedge fund is a major shareholder of Jaguar Animal Health?
Currently, no hedge funds are holding shares in JAGX
Company Description
Jaguar Animal Health
Jaguar Animal Health, operating under the ticker symbol JAGX, is a commercial-stage pharmaceuticals company that focuses on developing and commercializing gastrointestinal products for animals and humans. Operating primarily in the animal health and human health sectors, Jaguar is committed to identifying and advancing innovative, plant-based treatments derived from rainforest botanical extracts. The company's core product is Canalevia-CA1, a prescription drug designed to treat chemotherapy-induced diarrhea in dogs, reflecting Jaguar's commitment to addressing unmet medical needs in veterinary health.
JAGX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive breakthroughs in medical research with crofelemer and ongoing financial challenges. While there were significant advancements in clinical trials and potential regulatory approvals, the financial metrics showed a decline in revenue and increased losses.Read More>